Harry F. Dowling
Harry F. Dowling publishes mostly in Epidemiology, Infectious Diseases and Radiology, Nuclear Medicine and Imaging, on topics such as Pneumonia and Respiratory Infections, Pneumocystis jirovecii pneumonia detection and treatment and Historical Medical Research and Treatments.
- World rank
- #1,018,325 of 7,710,434 ranked researchers
- Rank in United States
- #331,837 of 1,627,098
- Works
- 175
- Citations
- 1.9k
- Citations per work
- 10.9
What does Harry F. Dowling research?
Harry F. Dowling's work is mostly in Medicine (44%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else9855.9%
- Health Sciences7744.1%
- Medicine7744.1%
- 1Epidemiology18% of their works
- 2Infectious Diseases7% of their works
- 3Radiology, Nuclear Medicine and Imaging6% of their works
- 4Pharmacology5% of their works
- 5Pulmonary and Respiratory Medicine4% of their works
- 6Public Health, Environmental and Occupational Health4% of their works
Research topics
- Pneumonia and Respiratory Infections
- Pneumocystis jirovecii pneumonia detection and treatment
- Historical Medical Research and Treatments
- Antibiotics Pharmacokinetics and Efficacy
- Respiratory viral infections research
- Bacterial Identification and Susceptibility Testing
- Antibiotic Use and Resistance
- Diphtheria, Corynebacterium, and Tetanus
Which keywords describe Harry F. Dowling's research?
The keywords of their largest research topics: Epidemiology, Antimicrobial Resistance, Community-Acquired Pneumonia, Pneumococcal Conjugate Vaccine, Pneumocystis, Pneumonia, Vaccine Development and Paul Ehrlich.
- Corynebacterium
- Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry
- Antibiotic Resistance
- Human Metapneumovirus
- Antibiotic Pharmacokinetics
- Paul Ehrlich
- Pneumonia
- Pneumococcal Conjugate Vaccine
- Antimicrobial Resistance
- Epidemiology
- Community-Acquired Pneumonia
- Pneumocystis
- Vaccine Development
- Translational Medicine
- Critically Ill Patients
- Respiratory Syncytial Virus
- Antimicrobial Stewardship
- Microorganism Identification
- Infections
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Epidemiology755 topics
- Antimicrobial Resistance533 topics
- Community-Acquired Pneumonia301 topic
- Pneumococcal Conjugate Vaccine301 topic
- Pneumocystis181 topic
- Pneumonia181 topic
- Vaccine Development182 topics
- Paul Ehrlich161 topic
- Translational Medicine161 topic
- Antibiotic Pharmacokinetics151 topic
- Critically Ill Patients151 topic
- Human Metapneumovirus101 topic
- Respiratory Syncytial Virus101 topic
- Antibiotic Resistance91 topic
- Antimicrobial Stewardship91 topic
- Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry91 topic
- Microorganism Identification91 topic
- Corynebacterium81 topic
- Infections81 topic
Where does Harry F. Dowling work?
Harry F. Dowling's main affiliation in the publication record is Illinois College, United States.
How many publications and citations does Harry F. Dowling have?
OpenAlex counts 175 works and 1,913 citations for Harry F. Dowling, an h-index of 23, ranking #1,018,325 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Harry F. Dowling. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.